Skip to content
Open access

Corneal Wavefront-Guided Transepithelial PRK Aligned to Comatic Axis After Corneal Cross-linking for Keratoconus.

Oct 2026 · Journal of refractive surgery · Vol 42 10, pp. e395-e403 · 0 citations · 9 references
Medicine

Abstract

Purpose

To evaluate the clinical outcomes of a comatic axis-adjusted corneal wavefront-guided transepithelial photorefractive keratectomy (TransPRK) protocol for visual rehabilitation in patients with keratoconus previously treated with corneal cross-linking (CXL).

Methods

In this prospective, non-randomized, consecutive case series, 24 eyes from 17 patients with stable stage I to III keratoconus after CXL underwent anterior wavefront-guided TransPRK centered on the comatic axis, using large optical zones and a tissue-saving ablation algorithm (⩽90 µm total, ⩽50 µm stromal). Main outcome measures included changes in corrected (CDVA) and uncorrected distance visual acuity, corneal higher order aberrations (HOAs), keratometric indices, and pachymetric parameters. Follow-up evaluations were performed at 1, 3, and 6 months.

Results

At 6 months, mean uncorrected distance visual acuity improved significantly from 0.83 ± 0.55 to 0.39 ± 0.20 logarithm of the minimum angle of resolution (logMAR) (P = .003), whereas CDVA improved from 0.21 ± 0.17 to 0.10 ± 0.08 logMAR (P = .002). Corneal HOAs decreased from 2.69 ± 1.18 to 1.95 ± 1.07 µm (P = .0002), with vertical coma showing the most significant reduction (P < .0001). Maximum keratometry values decreased from 54.32 ± 5.79 to 51.52 ± 4.93 diopters (P = .001). No eyes lost lines of CDVA or developed ectasia progression or clinically significant haze during follow-up.

Conclusions

Comatic axis-aligned anterior corneal wavefront-guided TransPRK in stable post-CXL keratoconus showed favorable short-term visual, aberrometric, and topographic outcomes while preserving corneal integrity, and may represent a feasible tissue-sparing strategy for optical regularization in irregular corneas.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.